SCHEMBL32669258

SCHEMBL32669258

COc1cc(/C=N/Nc2nc(N3CCOCC3)nc(N(CC3CC3)c3ccccc3)n2)ccc1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 9/20 0.57
▸ HPGD P15428 1/20 0.57
▸ PIKFYVE Q9Y2I7 1/20 0.53
▸ MAPT P10636 13/20 0.49
▸ ALDH1A1 P00352 7/20 0.49
▸ HTT P42858 2/20 0.49
▸ NPSR1 Q6W5P4 2/20 0.49
▸ PKM P14618 1/20 0.49
▸ AKR1C3 P42330 1/20 0.47
▸ AKR1C1 Q04828 1/20 0.47
▸ MEN1 O00255 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ LMNA P02545 2/20 0.45
▸ KDM4E B2RXH2 4/20 0.44
▸ POLB P06746 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32669225 0.83 PIKFYVE (0.76) GAAHPGDPIKFYVEMAPTALDH1A1
SCHEMBL32669254 0.83 PIKFYVE (0.57) GAAHPGDPIKFYVEMAPTALDH1A1
SCHEMBL32669248 0.76 MAPT (0.71) GAAHPGDPIKFYVEMAPTALDH1A1
SCHEMBL32669200 0.75 GAA (0.59) GAAHPGDMAPTALDH1A1HTT
SCHEMBL32669325 0.74 GAA (0.65) GAAHPGDMAPTALDH1A1HTT
SCHEMBL15890518 0.72 MTOR (0.65) GAAHPGDMAPTALDH1A1HTT
SCHEMBL22737369 0.72 GAA (0.59) GAAHPGDMAPTALDH1A1HTT
SCHEMBL24221970 0.71 PIKFYVE (0.70) GAAHPGDPIKFYVEMAPTALDH1A1
SCHEMBL31653615 0.71 MAPT (0.80) GAAHPGDMAPTALDH1A1HTT
SCHEMBL26135108 0.71 MAPT (0.80) GAAHPGDMAPTALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260034141-A1 METHODS AND COMPOSITIONS FOR TREATING MALIGNANT CANCERS 6J BIOTECHNOLOGY HONG KONG LTD (HK) 2026-02-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260034141-A1 METHODS AND COMPOSITIONS FOR TREATING MALIGNANT CANCERS MCL1, GLI1, BECN1 GAA 1558/4885HPGD 3950/4885PIKFYVE 1479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback